Clinical Trials Browser

Phase 4 × Lung Neoplasms × Ibandronic Acid × Clear all

NCT00492843 2016-02-17

Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis

Phase 4 Terminated

Lung Neoplasms